Hola,
¿eres nuevo aquí?

Regístrate gratis y conecta tu empresa con financiación pública, partners y proyectos.

Tengo cuenta

Regístrate

Ver video

CoaguPOC

Financiado

Cerrado

SMART POINT OF CARE DEVICE FOR SELF PATIENT MANAGEMENT OF THE ORAL ANTICOAGULANT...

SMART POINT OF CARE DEVICE FOR SELF PATIENT MANAGEMENT OF THE ORAL ANTICOAGULANT THERAPY The goal we seek in CoaguPOC project is to develop a ready to the market smart point-of-care device for self-patient management of the Oral Anticoagulant Therapy (OAT). OAT is a long-term or even chronic therapy necessary to inhib... ver más

31/08/2017

RELOGABLE

71K€

Presupuesto del proyecto: 71K€

Líder del proyecto

RELOGABLE La industria y el comercio por cuenta propia o de terceros de todo tipo de productos del papel o del carton. fabricacion, comercializacion e...

TRL 4-5 | 151K€

Fecha límite participación Sin fecha límite de participación.

Financiación concedida El organismo H2020 notifico la concesión del proyecto el día 2017-08-31

SMEInst-06-2016-2017: Accelerating market introduction of...

I+D

Cerrada hace 8 años

0% 70% 100%

Información adicional privada

No hay información privada compartida para este proyecto. Habla con el coordinador.

1 Participantes

RELOGABLE

50.00K€ | Lider

Conecta tu I+D

¿Tienes un proyecto y buscas un partner? Gracias a nuestro motor inteligente podemos recomendarte los mejores socios y ponerte en contacto con ellos. Te lo explicamos en este video

Proyectos interesantes

TEC2011-22746 TECNOLOGIAS DE APOYO PARA LA MONITORIZACION DEL ESTADO DE SA... 57K€ Cerrado

Cardiacom IMPLANT Intelligent human diagnostic and therapy platform 71K€ Cerrado

DESARROLLO DE UN NUEVO DISPOSITIVO PORTÁTIL P... DESARROLLO DE UN NUEVO DISPOSITIVO PORTÁTIL POC IVD DE USO P... 3M€ Cerrado

StrokeFlow Empowering physicians to provide every stroke treatment with... 3M€ Cerrado

HeartCycle Compliance and effectiveness in HF and CHD closed loop manag... 22M€ Cerrado

StentGuard Clinical validation of the First Implantable Sensor System f... 11M€ Cerrado

Duración del proyecto: 4 meses Fecha Inicio: 2017-04-19
Fecha Fin: 2017-08-31

Líder del proyecto

RELOGABLE La industria y el comercio por cuenta propia o de terceros de todo tipo de productos del papel o del carton. fabricacion, comercializacion e...

TRL 4-5 | 151K€

Presupuesto del proyecto 71K€

Fecha límite de participación Sin fecha límite de participación.

Descripción del proyecto The goal we seek in CoaguPOC project is to develop a ready to the market smart point-of-care device for self-patient management of the Oral Anticoagulant Therapy (OAT). OAT is a long-term or even chronic therapy necessary to inhibit the formation of potentially lethal blood clots in patients with high risk of thrombosis; e.g. strokes, the 2nd single largest cause of death in the world. Approximately 2% of the population are prescribed long-term oral anticoagulants, meaning that more than 10-12 million people are treated in Western Europe. OAT therapy needs regular tests to confirm correct dosage levels because the drugs have a narrow therapeutic window and small changes in systemic changes can give rise to adverse toxic effects. Tests are usually made once a month in a nursing service at the hospital or care center. The constant increase on the number of anti-coagulant patients (around 10% annually) is highly intensifying pressure and cost on the healthcare resources required to monitor, prevent and manage adverse events. The use of point-of-care coagulometers at home for self-monitoring may avoid unnecessary visits to hospitals or clinics while permitting more frequent monitoring and timely adjustment of anticoagulant dosing to avoid adverse events. The OAT self-management leads to important reductions on adverse events, as thrombosis (reduction by 50%), major hemorrhages (12%), death (18%) and thrombotic events (67%) as compared to ‘usual care‘. It also has a substantial impact on the quality of life of patients and their families, and important cost savings on the healthcare system. For instance, in UK a mere increase of 5% improved in average therapeutic range, led to a reduction of 550 strokes per year and associated cost saving of around €12,000 per patient. CoaguPOC aims bringing to the market the first low-cost and smart point of care device for OAT patients to self-monitor and self-manage their chronic condition. We aim to bring the lab to your pocket

Conecta tu I+D

Entra hoy

¿Olvidé mi contraseña?

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores